Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs

Overview of attention for article published in Genome Biology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

twitter: 7 X users

patent: 3 patents

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 85 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

CRISPR-CAS13 SYSTEM FOR TREATING UBE3A-ASSOCIATED DISEASES

Application WO-2023184108-A1

World Intellectual Property Organisation (WIPO)

CIRCULAR RNA DERIVED FROM RNA VIRUSES AND RELATED COMPOSITIONS AND METHODS

Application WO-2023133418-A3

World Intellectual Property Organisation (WIPO)

SYSTEMS, METHODS, AND COMPOSITIONS FOR ALTERING THE EXPRESSION OF ENDOGENOUS CIRCULAR RNAS

Application WO-2022192914-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.